| Revenue growth | Q2 revenue +18% YoY standalone, +26% QoQ; H1 +3%. |
|---|---|
| Margins | Standalone EBITDA margin ~11%, compressed on input costs; long-term 15-17% target. |
| Demand visibility | Europe weak; US steady; agro demand intact, pricing lagging; volatile. |
| Management confidence | Defensive-optimistic; repeated 'hope' and 'optimistic' without numbers. |
Growth
Consolidated revenue +16% YoY; H1 only +2%. Standalone EBITDA flat at ₹70.9 Cr on input and logistics costs. Receivables stretched, so sales growth is partly credit-funded.
Outlook
No quantified FY28 guidance. Pigment top line ₹600-650 Cr, crop protection margin 15-17% long-term, TiO2 restart undecided.
Risks
Receivable days 125+ vs 100-110 norm, TiO2 idle, sulphuric acid up 7-8x, Europe demand weak, dividend deferred.
Last quarter's promises, checked
Delivered
- Nano basket expansion → Nano DAP/NPK/zinc production started (= BEAT)
- Continuous debt repayment → consolidated debt ₹732 Cr to ₹661 Cr (= BEAT)
Partly delivered
- CP double-digit growth → Q2 standalone +18%, H1 +3% (= PARTIAL)
- ~₹130 Cr FY27 repayment → ₹64 Cr repaid, H1 implied (= PARTIAL)
Missed
- Positive EBITDA momentum (Q1 standalone ₹94 Cr) → standalone ₹70.9 Cr, flat YoY (= MISS)
- CP margin 15–17%+ → company standalone margin ~11%, CP undisclosed (= MISS)
Earnings Call Transcript filed with NSE, NSE: MOL. Summary written with AI assistance from the document.
Meghmani Organics Ltd: key numbers
- Share price
- ₹55.62
- Market cap
- ₹1,414 Cr
- Revenue (annual)
- ₹2,174 Cr
- Net profit (annual)
- ₹28.74 Cr
- P/E (TTM)
- 16.3×Sector 34.8×
- Promoter holding
- 48.95%+0.00% QoQ
- FII holding
- 0.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Meghmani Organics Ltd
All →Meghmani Organics Results Update
MOL reported Q2 FY27 revenue of ₹658.2 crore, up 18% YoY, with net profit of ₹45.3 crore. EBITDA margin eased to 10.8% on elevated input costs.
Meghmani Organics Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue ₹658.2 Cr (+18% YoY), EBITDA flat at ₹70.9 Cr, margin 10.8% under cost pressure; PAT ₹45.3 Cr (+6%). Strategy: TiO2 import substitution and nano fertiliser expansion.
Meghmani Organics Q2 FY27 Results: Net Profit ₹33.9 Cr, Up 192.2% YoY
Meghmani Organics Ltd reported revenue from operations of ₹666.9 Cr (+15.5% YoY) and net profit of ₹33.9 Cr (+192.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹33.9 Cr · +192.2% YoY
Meghmani Organics Credit Rating
India Ratings assigned Meghmani Organics' bank loan facilities of INR 11,000 million a rating of IND A/Stable/IND A1. The filing encloses the rating letter and a facilities breakup.
Meghmani Organics Board Meeting Date
Meghmani Organics will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The meeting is a future notice, so no results are yet reported.
Meghmani Organics Other Announcement
Meghmani Organics Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.